Previous experiments of our group in mouse high-grade gliomas identified a network of critical tumor-suppressive Sox2 targets, whose inhibition is involved in glioma CSC maintenance, therefore defining new therapeutic targets [12]. Here, SOX2 is linked to neoplasm.